Diabetes Mellitus is estimated to affect over 124 million individuals worldwide. The rising prevalence of type 1 diabetes and the projected global increase in type 2 diabetes attests to the urgent need for the development of safer and more effective treatment strategies. This book provides an overview of the latest developments in diabetes research, and critically assesses both current therapies and potential new treatment compounds. Methodological aspects of clinical trials in diabetes and related regulatory issues are examined in detail. Key features * Written by an experienced team of authors with a proven track record in publishing for this market * Up-to-date and comprehensive coverage of recent clinical trials and research studies * Features a useful evaluation of future trends in diabetes research and treatment
Sprache
Verlagsort
Verlagsgruppe
Cambridge University Press
Zielgruppe
Maße
Höhe: 241 mm
Breite: 164 mm
Dicke: 18 mm
Gewicht
ISBN-13
978-1-84110-038-8 (9781841100388)
Copyright in bibliographic data and cover images is held by Nielsen Book Services Limited or by the publishers or by their respective licensors: all rights reserved.
Schweitzer Klassifikation
General Overview of Diabetes / Complications of Diabetes / Current Treatment Strategies to Prevent Diabetes / Current Treatment Strategies to Improve Glycemic Control / Assessment of Glycemic Control / Current Treatment Strategies to Prevent Diabetic Complications / Review of Antidiabetic Compunds Developed in the Modern Era / Review of Antidiabetic Compounds in the Pipeline / Regulatory Expectation for Antidiabetic Therapies / Methodological Considerations: Diabetic Microvascular Complications / Methodological Considerations: Diabetes-related Cognitive Dysfunction / Special Methodological Considerations / Concluding Remarks
